SOBERANA Plus

2 trials

Sponsors

Finlay Vaccine Institute (IFV)

Conditions

COVID-19 COVID-19 SARS-CoV-2COVID-19 COVID-19 SARS-CoV2

Phase 2

SOBERANA PLUS PEDIATRIA

Active, not recruitingRPCEC00000391

Finlay Vaccine Institute (IFV)COVID-19 COVID-19 SARS-CoV-2

Start: 2021-09-29Target: 520Updated: 2026-08-10

Unknown Phase

SOBERANA PLUS TURIN

Active, not recruitingRPCEC00000397

Finlay Vaccine Institute (IFV)COVID-19 COVID-19 SARS-CoV2

Start: 2021-11-16Updated: 2026-08-10